glp-1 lilly Eli to seek approval of new weight-loss drug this year Administration Anounces Landmark GLP-1 Pricing

Since its US FDA approval in June 2021 and subsequent EU and Japan approval in 2022 and 2023, respectively, for chronic weight management, WEGOVY has rapidly gained traction

Gastroenterology 2011;141:150-6.ArticlePubMedPMC 12

Reduced calorie intake Semaglutide suppresses appetite, which often leads to eating significantly fewer calories

Tirzepatide is metabolized via proteolytic cleavage and does not undergo hepatic cytochrome P450 metabolism, reducing the likelihood of interactions with medications metabolized through these pathways

Patients who have switched to other glucose-lowering medicines during the shortage but still have a valid GLP-1 therapy prescription such as Ozempic should consult their doctor for guidance

Besides this, increasing awareness of the advantages of these drugs through marketing efforts and direct-to-consumer advertising, particularly on social media, and a favorable regulatory landscape are enabling approvals and boosting demand in the market